Is Privia Health Group Inc (PRVA) overvalued? · P/E 135, $2.90B cap
Privia Health Group Inc (PRVA) is a health information services company listed on NASDAQ.
This page asks whether Privia Health Group Inc (PRVA) looks expensive on cached numbers — not a short thesis.
No cached income statement for PRVA, so there is no earnings base to call rich or cheap.
PRVA currently screens at market cap $2.90B and trailing P/E 135.4. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next PRVA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the PRVA stock page for the full model, not this heading.
Not investment advice.